SOFT TISSUE SARCOMAS
Clinical trials for SOFT TISSUE SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMAS trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo drug trial targets Hard-to-Treat sarcomas
Disease control Recruiting nowThis early-phase trial is testing a combination of two drugs, gemcitabine and nab-sirolimus, in people with advanced leiomyosarcomas or soft-tissue sarcomas that have lost function in the TSC1 or TSC2 genes. The main goal is to find a safe and tolerable dose. The study plans to e…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for sarcoma patients: immunotherapy plus chemo shows promise
Disease control Recruiting nowThis study tests a new combination of drugs (tislelizumab, liposomal doxorubicin, and ifosfamide) as a first treatment for people with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The goal is to see if this combo shrinks tumors and is safe. About …
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Gene signature may forecast chemo response in sarcoma patients
Knowledge-focused Recruiting nowThis study looks at whether a genetic test called CINSARC can predict how well chemotherapy works in people with soft-tissue sarcoma. Researchers will collect tumor and blood samples from 205 participants before they receive standard chemotherapy and surgery. The goal is to see i…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC